Mechelen

City
Favicons?domain=wwwMedical News Today | November 04, 2009

More Than 80 Percent Of HCV Genotype 1 Treatment-Naive Patients Achieved Sustained Virologic Response With Twice-Daily Telaprevir-Based Regimen

Tibotec BVBA is a global pharmaceutical and research development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Yardley, PA and Cork, Ireland. Tibotec is dedicated to the discovery and...

In this article: Telaprevir, Ribavirin, Hepatitis, Pegasys, American Association, Rash, Tibotec, Medical advice, and Cancer

Connections-toggle
Filter by
or